Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 08 Sep 2023

Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma

in Cancer Immunity and Immunotherapy

Rebecca Charles
Divine Madhu
Alexander Powles
Adam Boyde
Owen Hughes
Nagappan Kumar
Sing Yu Moorcraft

Frontiers in Oncology

doi 10.3389/fonc.2023.1242560

2,198 views
1 citation

Mini Review

Published on 07 Sep 2023

Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment

in Cancer Immunity and Immunotherapy

Annemarie D. Jagielo
Catherine Benedict
David Spiegel

Frontiers in Oncology

doi 10.3389/fonc.2023.1269378

3,794 views
4 citations

Review

Published on 05 Sep 2023

ExoPD-L1: an assistant for tumor progression and potential diagnostic marker

in Cancer Immunity and Immunotherapy

Rong Hu
Md Shoykot Jahan
Lijun Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1194180

3,055 views
10 citations

Retraction

Published on 04 Sep 2023

Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy

in Cancer Immunity and Immunotherapy

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1285219

3,747 views

Review

Published on 01 Sep 2023

Current status of clinical trial research and application of immune checkpoint inhibitors for non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Fuli Wang
Teng Xia
Zhiqiang Li
Xuzhu Gao
Xinjian Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1213297

5,201 views
14 citations

Case Report

Published on 30 Aug 2023

Intracavitary cardiac metastasis of cervical squamous cell carcinoma with immune thrombocytopenia: a rare case report

in Cancer Immunity and Immunotherapy

Ning Liu
Deguan Lv
Raydonna Rachel Schneider
Hongyan Yang
Mingyan Zhang
Yanan Liu
Meili Sun

Frontiers in Oncology

doi 10.3389/fonc.2023.1239606

2,191 views
2 citations

Original Research

Published on 29 Aug 2023

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer

in Cancer Immunity and Immunotherapy

Ming Zhong
Lian Gong
Na Li
Hui Guan
Kai Gong
Yong Zhong
Enyi Zhu
Xiaohua Wang
Shan Jiang
Jinhong Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1179897

4,627 views
6 citations

Systematic Review

Published on 29 Aug 2023

Prognostic significance of STING expression in solid tumor: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Younghoon Kim
Nam-Yun Cho
Lingyan Jin
Hye Yeong Jin
Gyeong Hoon Kang

Frontiers in Oncology

doi 10.3389/fonc.2023.1244962

2,977 views
9 citations

Editorial

Published on 28 Aug 2023

Editorial: Therapeutic antibody domains against cancer

in Cancer Immunity and Immunotherapy

Qi Zhao
Wei Li
Dimiter S. Dimitrov

Frontiers in Oncology

doi 10.3389/fonc.2023.1274911

1,252 views

Mini Review

Published on 24 Aug 2023

Targeting collagen in tumor extracellular matrix as a novel targeted strategy in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Jiayang Liu
Danjie Pan
Xuan Huang
Songna Wang
Huaning Chen
Yi Zhun Zhu
Li Ye

Frontiers in Oncology

doi 10.3389/fonc.2023.1225483

4,253 views
9 citations

Review

Published on 24 Aug 2023

Research progress of nanovaccine in anti-tumor immunotherapy

in Cancer Immunity and Immunotherapy

Min Yao
Xiyu Liu
Zhangbo Qian
Dianfa Fan
Xinjun Sun
Liping Zhong
Pan Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1211262

5,207 views
20 citations

Review

Published on 23 Aug 2023

Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review

in Cancer Immunity and Immunotherapy

Harrison D. Collier-Bain
Frankie F. Brown
Adam J. Causer
Annabelle Emery
Rebecca Oliver
Sally Moore
James Murray
James E. Turner
John P. Campbell

Frontiers in Oncology

doi 10.3389/fonc.2023.1244090

4,752 views
7 citations

Original Research

Published on 23 Aug 2023

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma

in Cancer Immunity and Immunotherapy

Licheng Wang
Yaru Zhu
Zhen Ren
Wenhuizi Sun
Zhijing Wang
Tong Zi
Haopeng Li
Yan Zhao
Xin Qin
Dacheng Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1147805

2,105 views
5 citations

Original Research

Published on 22 Aug 2023

The identification of tumor antigens and immune subtypes based on the development of immunotherapies targeting head and neck squamous cell carcinomas resulting from periodontal disease

in Cancer Immunity and Immunotherapy

Yangju Fu
Yongbo Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1256105

1,932 views

Original Research

Published on 21 Aug 2023

Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Yexin Yuan
Yue Su
Yingxi Wu
Yafei Xue
Yunze Zhang
Yangyang Zhang
Min Zheng
Ting Chang
Yan Qu
Tianzhi Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1229905

2,869 views
1 citation

Original Research

Published on 21 Aug 2023

Upregulated FADD is associated with poor prognosis, immune exhaustion, tumor malignancy, and immunotherapy resistance in patients with lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Miao He
Yingying He
Jian Xu
Youcai Zhang
Xiaoyu Cao
Li Wang
Feng Luo

Frontiers in Oncology

doi 10.3389/fonc.2023.1228889

2,206 views
1 citation